Company: PTHS
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001753926-25-001764
Chunk: 0

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
1

PELTHOS
THERAPEUTICS INC.  

CONDENSED
CONSOLIDATED BALANCE SHEETS 

(in
thousands, except share and per share amounts)

    September 30, 2025  
    December 31, 2024 

    (Unaudited)  

    ASSETS 

    Cash and cash equivalents 
    $14,203  
    $513 

    Restricted cash, current 
     50  
     — 

    Accounts receivable, net 
     7,988  
     — 

    Inventory, net 
     24,096  
     — 

    Prepaid expenses and other current assets 
     3,424  
     856 

    Total current assets 
     49,761  
     1,369 

    Property and equipment, net 
     10,174  
     — 

    Operating lease right-of-use assets, net 
     3,352  
     — 

    Intangible assets, net 
     32,521  
     — 

    Goodwill 
     30,625  
     — 

    Total assets 
    $126,433  
    $1,369 

    LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) 

    Accounts payable 
    $5,666  
    $1,897 

    Accrued expenses 
     11,890  
     — 

    Operating lease liabilities, current portion 
     631  
     — 

    Deferred revenue, current portion 
     1,019  
     — 

    Loan payable, net of debt discount 
     —  
     2,054 

    Loan payable - related party, net of debt discount 
     —  
     132 

    Other liabilities 
     5,562  
     — 

    Total current liabilities 
     24,768  
     4,083 

    Operating lease liabilities, net of current portion 
     2,849  
     — 

    Deferred revenue, net of current portion 
     1,522  
     — 

    Deferred income tax liability 
     12,866  
     — 

    Other